Search research articles
Contact Us
Filters
Showing results (121-130 of 161) with videos related to
Page
of 17
Sort By:
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
January 1, 1994
Mouse chromosome 7
M H Brilliant, R W Williams, C J Conti, et al.
Carcinogenesis
|
November 1, 1990
Early expression of type I K13 keratin in the progression of mouse skin papillomas
I Gimenez-Conti, C M Aldaz, A B Bianchi, et al.
Cancer Research
|
October 10, 1998
Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen
R L Binder, G R Johnson, P M Gallagher, et al.
Cancer Research
|
December 15, 1991
Alterations of the p53 tumor suppressor gene during mouse skin tumor progression
B Ruggeri, J Caamano, T Goodrow, et al.
Carcinogenesis
|
January 14, 1999
Angiogenesis is an early event in the development of chemically induced skin tumors
M F Bolontrade, M C Stern, R L Binder, et al.
Molecular Carcinogenesis
|
August 17, 1999
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
S M Fischer, H H Lo, G B Gordon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 1998
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53
A M Pierce, I B Gimenez-Conti, R Schneider-Broussard, et al.
Molecular and Cellular Biology
|
August 24, 1999
E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model
A M Pierce, R Schneider-Broussard, I B Gimenez-Conti, et al.
Cancer Research
|
June 25, 1992
Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice
I B Gimenez-Conti, A B Bianchi, S M Fischer, et al.
Cancer Research
|
December 1, 1996
Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels
F Larcher, A I Robles, H Duran, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 161) with videos related to
Sort By:
Page
of 17
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
January 1, 1994
Mouse chromosome 7
M H Brilliant, R W Williams, C J Conti, et al.
Carcinogenesis
|
November 1, 1990
Early expression of type I K13 keratin in the progression of mouse skin papillomas
I Gimenez-Conti, C M Aldaz, A B Bianchi, et al.
Cancer Research
|
October 10, 1998
Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen
R L Binder, G R Johnson, P M Gallagher, et al.
Cancer Research
|
December 15, 1991
Alterations of the p53 tumor suppressor gene during mouse skin tumor progression
B Ruggeri, J Caamano, T Goodrow, et al.
Carcinogenesis
|
January 14, 1999
Angiogenesis is an early event in the development of chemically induced skin tumors
M F Bolontrade, M C Stern, R L Binder, et al.
Molecular Carcinogenesis
|
August 17, 1999
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
S M Fischer, H H Lo, G B Gordon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 1998
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53
A M Pierce, I B Gimenez-Conti, R Schneider-Broussard, et al.
Molecular and Cellular Biology
|
August 24, 1999
E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model
A M Pierce, R Schneider-Broussard, I B Gimenez-Conti, et al.
Cancer Research
|
June 25, 1992
Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice
I B Gimenez-Conti, A B Bianchi, S M Fischer, et al.
Cancer Research
|
December 1, 1996
Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels
F Larcher, A I Robles, H Duran, et al.
Page
of 17